Latest news about Biofil Chemicals
Biofil Chemicals
34.24
-0.13(-0.38%)
Company Performance:
View Company Insights1D-0.38%
1M+0.56%
6M-4.49%
1Y-29.42%
5Y-50.84%
More news about Biofil Chemicals
14Feb 26
Biofil Chemicals and Pharmaceuticals Limited Publishes Unaudited Financial Results for Q3 FY25
Biofil Chemicals and Pharmaceuticals Limited has published its unaudited financial results for the quarter and nine months ended December 31, 2025, in Free Press Mumbai & Indore and Choutha Sansar newspapers on February 14, 2026. The publication complies with SEBI Listing Obligations and Disclosure Requirements Regulations 2015, following board approval on February 13, 2026. The results include Quick Response Code and webpage access for complete financial information.
03Dec 25
Biofil Chemicals and Pharmaceuticals Pays Rs 4.24 Lakh Fine to BSE Under Protest
Biofil Chemicals and Pharmaceuticals Limited has paid a fine of ₹4,24,823.60 to BSE Limited under protest for alleged non-compliance with SEBI LODR Regulation 17(1)(c). The company had previously filed waiver applications with NSE and BSE. Despite the fine, Biofil Chemicals states there is no material impact on its financial or operational activities, supported by recent balance sheet data showing growth in total assets, current assets, and total equity.
14Nov 25
Biofil Chemicals Reports Profit Turnaround Despite Revenue Decline in Q2 FY2026
Biofil Chemicals and Pharmaceuticals Limited reported a significant profitability turnaround for Q2 FY2026. Despite a 40.20% year-on-year revenue decline to Rs 199.73 crore, the company posted a net profit of Rs 241.10 crore, compared to a loss of Rs 244.19 crore in the same period last year. The basic and diluted EPS improved to Rs 1.48 from Rs 0.01 in Q2 FY2025. The company's total assets stood at Rs 5,536.35 crore, with total equity of Rs 2,130.43 crore as of September 30, 2025.
15Sept 25
Biofil Chemicals Shareholders Overwhelmingly Approve Sale of Industrial Land Leasehold Rights
Biofil Chemicals and Pharmaceuticals Limited received 99.93% shareholder approval to sell leasehold rights of 80,156 square meters of vacant industrial land in Pithampur, Madhya Pradesh. The resolution passed through a postal ballot, with 8,974,224 votes in favor and 6,503 against. The land is located at Plot No. 8, Sector-3, Kheda Industrial Estate, Pithampur, District Dhar. Out of 25,845 total shareholders, 23,017 received postal ballot notices via email.
23Aug 25
Biofil Chemicals Appoints Smitesh Shah as Additional Promoter Director
Biofil Chemicals & Pharmaceuticals Limited has appointed Mr. Smitesh Shah as an Additional Director in the category of Promoter Non-Executive Non-Independent Director, effective August 23, 2025. Mr. Shah, 65, brings 45 years of pharmaceutical industry experience and is the uncle of the company's Chairman and Managing Director. The appointment, subject to shareholder approval at the upcoming 40th AGM, was recommended by the Nomination and Remuneration Committee. Mr. Shah holds directorships in 6 other companies and is not debarred from holding office by any SEBI Order.
04Aug 25
Biofil Chemicals And Pharma to Sell Industrial Land for Minimum ₹16 Crore
Biofil Chemicals And Pharmaceuticals Limited plans to sell 80,156 square meters of vacant industrial land in Pithampur, Madhya Pradesh, for a minimum of ₹16 crore. The sale, subject to shareholder and MPIDC approval, could impact 20.18% of the company's turnover and 49.09% of its net worth. The board aims to complete the transaction by December 31, 2025, with the buyer not being a related party.
04Aug 25
Biofil Chemicals to Sell Pithampur Industrial Land for Rs 16 Crore
Biofil Chemicals and Pharmaceuticals Limited plans to sell its 80,156 square meter industrial land in Pithampur, Madhya Pradesh, for a minimum of Rs 16 crore. The land contributed 20.18% of the company's total turnover and 49.09% of its net worth last year. The sale, approved by the Board, requires regulatory approvals including MPIDC and shareholder consent via postal ballot. The transaction is expected to complete by December 31, 2025.
Industry Peers
Sun Pharmaceutical
Divis Laboratories
Torrent Pharmaceuticals
Cipla
Zydus Life Science
Dr Reddys Laboratories
Lupin
Mankind Pharma
Aurobindo Pharma
Laurus Labs
1,788.50
(-0.08%)
6,576.50
(+0.67%)
4,368.50
(+1.17%)
1,375.20
(-0.30%)
1,076.60
(-0.16%)
1,263.30
(-0.84%)
2,261.20
(+0.51%)
2,369.50
(+3.07%)
1,440.40
(+0.78%)
1,394.30
(+0.85%)
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
